Sodium azide
|
CAS
26628-22-8
|
NaN3
|
RTECS
VY8050000
|
Synonyms & Trade Names
Azide, Azium, Sodium salt of hydrazoic acid
|
DOT ID & Guide
1687 / 153
|
Exposure Limits
|
NIOSH REL: C 0.1 ppm (as HN3) [skin] C 0.3 mg/m3 (as NaN3) [skin]
|
OSHA PEL†: none
|
IDLH
N.D.
See: IDLH INDEX
|
Conversion
|
Physical Description
Colorless to white, odorless, crystalline solid. [pesticide] [Note: Forms hydrazoic acid (HN3) in water.]
|
MW: 65.0
|
BP: Decomposes
|
MLT: 527°F (Decomposes)
|
Sol(63°F): 42%
|
VP: ?
|
IP: 11.70 eV
|
|
Sp.Gr: 1.85
|
Fl.P: ?
|
UEL: ?
|
LEL: ?
|
|
Combustible Solid (if heated above 572°F).
|
Incompatibilities & Reactivities
Acids, metals, water [Note: Over a period of time, sodium azide may react with copper, lead, brass, or solder in plumbing systems to form an accumulation of the HIGHLY EXPLOSIVE compounds of lead azide & copper azide.]
|
Measurement Methods
OSHA ID121, ID211
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Water flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
Not available.
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin; headache, dizziness, lassitude (weakness, exhaustion), blurred vision; low blood pressure, bradycardia; kidney changes
|
Target Organs
Eyes, skin, central nervous system, cardiovascular system, kidneys
|
See also: INTRODUCTION
See ICSC CARD: 0950 |